[1] Grundy SM, Cleeman JI, Merz CNB, Brewe HB, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Journal of the American College of Cardiology. 2004;44(3):720-32.
[2] Cho JK, Han TK, Kang HS. Combined effects of body mass index and cardio/respiratory fitness on serum vaspin concentrations in Korean young men. European journal of applied physiology. 2010;108(2):347-53.
[3] Fatouros IG, Chatzinikolaou A, Tournis S, Nikolaidis M G, Jamurtas AZ, Douroudos II, et al. Intensity of resistance exercise determines adipokine and resting energy expenditure responses in overweight elderly individuals. Diabetes care. 2009;32(12):2161-7.
[4] Suliga E,
Kozieł D,
Cieśla E,
Rębak D, et al. Associations Between Vaspin Rs2236242 Gene Polymorphism, Walking Time and the Risk of Metabolic Syndrome. 2019; 22(1):41-48.
[8] Youn BS, Kloting N, Kratzsch J. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes. 2008;57(2): 372-377.
[9] Gulcelik NE, Karakaya J, Gedik A. Serum vaspin levels in type 2 diabetic women in relation to microvascular complications. Eur J Endocrinol. 2009;160(1):65-70.
[10] Lee MK, Jekal Y, Im JA, Kim E, Lee SH, Park JH, et al. Reduced serum vaspin concentrations in obese children following short-term intensive lifestyle modification. Clin Chim Acta. 2009;411(5-6):381-385.
[11] Oberbach A, Kirsch K, Lehmann S, Schlichting N, Fasshauer M, Zarse K, et al. Serum vaspin concentrations are decreased after exercise-induced oxidative stress. Obes. Facts. 2010;3(5):328–331.
2017;30(1):229-234.
[15] Hida K, Wada J, Eguchi J, Zhang H, Baba M, Seida A, Hashimoto I, et al. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci U S A. .2005;102(30):10610-10615.